KERXKERYX BIOPHARMACEUTICALS
CUSIP 492515101 · common stock
No tracked investor reported shares of KERYX BIOPHARMACEUTICALS (KERX) for Q4 2018. Seth Klarman sold out of its position this quarter.
Holders · Q4 2018
0
New holders
0
Value held
$0
Quarter-end price (est.)
—
Investors holding KERX · Q4 2018
No tracked investor reported shares this quarter.
Sold out this quarter
| Investor | Prior weight | Prior shares | Prior value | Change |
|---|---|---|---|---|
| Seth Klarman | 0.67% | 25,791,678 | $87.7M | EXIT |
History
| Quarter | Holders | New | Sold out | Value held | Quarter-end price (est.) |
|---|---|---|---|---|---|
| Q4 2018 | 0 | 0 | 1 | $0 | — |
| Q3 2018 | 1 | 0 | 0 | $87.7M | $3.40 |
| Q2 2018 | 1 | 0 | 0 | $97M | $3.76 |
| Q1 2018 | 1 | 0 | 0 | $105.5M | $4.09 |
| Q4 2017 | 1 | 0 | 0 | $119.9M | $4.65 |
| Q3 2017 | 1 | 0 | 0 | $183.1M | $7.10 |
| Q2 2017 | 1 | 0 | 0 | $186.5M | $7.23 |
| Q1 2017 | 1 | 0 | 0 | $158.9M | $6.16 |
| Q4 2016 | 1 | 0 | 0 | $151.1M | $5.86 |
| Q3 2016 | 1 | 0 | 0 | $137M | $5.31 |
| Q2 2016 | 1 | 0 | 0 | $170.7M | $6.62 |
| Q1 2016 | 1 | 0 | 0 | $120.4M | $4.67 |
| Q4 2015 | 1 | 0 | 0 | $130.2M | $5.05 |
| Q3 2015 | 1 | 0 | 0 | $84.5M | $3.28 |
| Q2 2015 | 1 | 0 | 0 | $257.4M | $9.98 |
| Q1 2015 | 1 | 0 | 0 | $284.9M | $12.73 |
| Q4 2014 | 1 | 0 | 0 | $258.9M | $14.15 |
| Q3 2014 | 1 | 0 | 0 | $251.6M | $13.75 |
| Q2 2014 | 1 | 0 | 0 | $162.1M | $15.38 |
| Q1 2014 | 1 | 1 | 0 | $107.5M | $17.04 |